CHEK2 and breast cancer: We examined the mutation frequency of BRCA1, BRCA2, CHEK2 and ATM in women who had developed a second primary breast tumour at least 1 year after a first breast cancer diagnosed before the age of 50 years, with or without RT for their first breast cancer.